Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

NCT: NCT07586995 · ENROLLING_BY_INVITATION

NCT IDNCT07586995
StatusENROLLING_BY_INVITATION
Start Date2026-06
Completion2033-08

Brief Summary

The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.

Frequently Asked Questions

What is A Post-Market Assessment of the Safety and Performance of the TriClip™ System?

A Post-Market Assessment of the Safety and Performance of the TriClip™ System is a clinical trial registered under NCT07586995. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07586995?

The current status of NCT07586995 (A Post-Market Assessment of the Safety and Performance of the TriClip™ System) is: ENROLLING_BY_INVITATION.

When did A Post-Market Assessment of the Safety and Performance of the TriClip™ System start?

A Post-Market Assessment of the Safety and Performance of the TriClip™ System started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.